trial
as of 2026-07-01Evaluation of the Efficacy of Transcranial Magnetic Stimulation on Resistant Auditory Hallucinations in Schizophrenia
NCTId NCT06599372
at a glance
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Recruiting
Enrollment
30 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
Triple
Start
2022-07-11
Primary completion
2027-07
Eligibility
ALL · 18 Years
Interventions & indications
Sponsors
Dominique JANUELLead Sponsor
Investigators
2
Dominique Januel, MD, PhDStudy Director
NOOMANE BOUAZIZ, MDPrincipal Investigator
Sites
1 total
Neuilly-sur-Marne, France
Facts & assertions
4 sourced
Enrollment
30
Phase
NA
Primary Completion Date
2027-07
Status
RECRUITING
relationships
The graph out of here
drug
drug
drug
lead_sponsor
company
indication
investigator
person